Heron Therapeutics (HRTX) Other Gross PP&E Adjustments: 2010-2025
Historic Other Gross PP&E Adjustments for Heron Therapeutics (HRTX) over the last 7 years, with Sep 2025 value amounting to -$708,000.
- Heron Therapeutics' Other Gross PP&E Adjustments rose 79.59% to -$708,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $17.8 million, marking a year-over-year increase of 854.88%. This contributed to the annual value of $22.0 million for FY2024, which is 119.06% up from last year.
- As of Q3 2025, Heron Therapeutics' Other Gross PP&E Adjustments stood at -$708,000, which was up 49.46% from -$1.4 million recorded in Q2 2025.
- Heron Therapeutics' Other Gross PP&E Adjustments' 5-year high stood at $22.0 million during Q4 2024, with a 5-year trough of -$15.6 million in Q1 2021.
- For the 3-year period, Heron Therapeutics' Other Gross PP&E Adjustments averaged around -$380,545, with its median value being -$3.5 million (2024).
- Data for Heron Therapeutics' Other Gross PP&E Adjustments shows a peak YoY soared of 1,822.64% (in 2023) over the last 5 years.
- Quarterly analysis of 5 years shows Heron Therapeutics' Other Gross PP&E Adjustments stood at -$12.1 million in 2021, then skyrocketed by 95.18% to -$583,000 in 2022, then skyrocketed by 1,822.64% to $10.0 million in 2023, then skyrocketed by 119.06% to $22.0 million in 2024, then soared by 79.59% to -$708,000 in 2025.
- Its Other Gross PP&E Adjustments was -$708,000 in Q3 2025, compared to -$1.4 million in Q2 2025 and -$2.1 million in Q1 2025.